netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 15 of 15


Details
LDL Link Added : MHRA Drug Safety Update (May 2016): BCR-ABL tyrosine kinase inhibitors: risk of hepatitis B reactivation : https://www.gov.uk/drug-safety-update/bcr-abl-tyrosine-kinase-inhibitors-risk-of-hepatitis-b-reactivation
11/07/2023 17:48:37
(dmcdermott )
UPD sitematrix Changed from 0 to
11/07/2023 17:47:54
(dmcdermott )
UPD FurtherInformation Changed from

  • Approved for the first-line treatment of adults with chronic phase Philadelphia-chromosome-positive CML in line with NICE and NHS Commissioning Policy

to
11/07/2023 17:47:54
(dmcdermott )
UPD Nilotinib (Tasigna®) =
11/07/2023 17:47:54
(dmcdermott )
UPD Nilotinib updated
24/01/2019 13:35:05
(DavidS )
UPD upoNilotinib updated
09/05/2018 11:40:14
(LoweryM )
UPD Nilotinib updated
09/08/2017 16:10:41
(DavidS )
UPD Nilotinib B
03/02/2017 14:58:13
(LoweryM )
UPD Nilotinib b
01/02/2017 15:26:47
(DavidS )
LDL Link Added : NICE TA426: Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia : https://www.nice.org.uk/guidance/ta426/
31/01/2017 16:06:41
(DavidS )
UPD Nilotinib b
31/01/2017 16:05:19
(DavidS )
LDL Link Added : NICE TA425: Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia : https://www.nice.org.uk/guidance/ta425
31/01/2017 16:04:33
(DavidS )
UPD Nilotinib b
23/01/2017 15:20:57
(WhitehallJ )
UPD Nilotinib 150mg and 200mg capsules b
23/01/2017 11:03:57
(WhitehallJ )
UPD Nilotinib (Tasigna®) build
28/11/2016 15:45:23
(DavidS )

 

 
netFormulary